Document is current
Any future updates will be listed below
-
Authors
Galli, Eugenio https://orcid.org/0000-0002-2839-916X
Di Rocco, Alice
Pansini, Ilaria
Frondizi, Federico
Di Palma, Martina
Metafuni, Elisabetta https://orcid.org/0000-0002-4780-1273
Piccirillo, Nicola https://orcid.org/0000-0002-1688-1987
Bianchi, Maria
Cingolani, Antonella
Torelli, Giovanni Fernando
Hohaus, Stefan
Chiusolo, Patrizia https://orcid.org/0000-0002-1355-1587
Iori, Anna Paola
Sica, Simona https://orcid.org/0000-0003-2426-3465
Martelli, Maurizio
Sorà, Federica https://orcid.org/0000-0002-9607-5298
- License Information
-
More Information
Article History
Received: 10 March 2023
Revised: 2 August 2023
Accepted: 17 August 2023
First Online: 4 September 2023
Competing interests
: EG received travel grants from Kite Gilead and honoraria for speakers bureau from Novartis and advisory board from Bristol Myers Squibb. SH received honoraria for participating to advisory boards from Novartis. PC received honoraria for participating to advisory boards from Bristol Myers Squibb and Novartis. All other authors declare no competing conflict of interest.
